ArticleAbdominal radiology (New York)2026
Intratumoral habitat imaging for progression-free survival prediction of patients with high-risk, non-metastatic clear cell renal cell carcinoma.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeAccurate risk stratification for patients with high-risk, non-metastatic clear cell renal cell carcinoma (ccRCC) remains a clinical challenge. Our aim is to develop and validate an imaging model based on intratumoral habitat imaging for non-invasive assessment of progression-free survival (PFS) in this high-interest population.
methodsA retrospective analysis was performed on a cohort of 220 patients with ccRCC from three hospitals. Preoperative CT images and clinical data were comprehensively analyzed. K-mean clustering method was used to generate habitat subregions using contrast-enhanced CT images. Radiomic features were extracted from habitat subregions and the entire tumor, Random Survival Forest for PFS prediction were constructed using conventional radiomics features, habitat subregions-derived radiomics. Model evaluation included calibration curve, receiver operating characteristic curve (ROC) and Kaplan-Meier survival analysis.
resultsThe Habitat 3 model demonstrated favorable prognostic performance. In the training cohort, 1-, 3-, and 5-year AUCs were 0.92, 0.92, and 0.78, respectively. In the external test set, the model maintained robustness with 1-, 3-, and 5-year AUCs of 0.87, 0.74, and 0.94, outperforming traditional radiomics and other Habitat models. Furthermore, patients stratified by Habitat 3 showed significant survival differences between high-risk and low-risk groups in both cohorts.
conclusionWe proposed a habitat-based imaging technique for the preliminary analysis of high-risk ccRCC. This retrospective study suggests that habitat signatures are associated with PFS, serving as a potential non-invasive complement to provide insights into tumor heterogeneity.
Indexed as
Identifiers
42142297What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.